Mandate

Vinge has advised Stendörren in connection with a bond issue of up to SEK 1,000 million

August 14, 2017

Vinge has advised Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with a bond issue of up to SEK 1,000 million senior unsecured floating rate bonds.

The bonds have a tenor of three years and a floating interest rate of three-months Stibor plus 4 per cent. ABG Sundal Collier AB and Swedbank have acted as financial advisors to Stendörren. Swedbank also acted as Issuing Agent.

The proceeds from the initial bond issue will primarily be used for refinancing of Stendörren’s outstanding SEK 750 million bonds, which will be made through a repurchase offer. The proceeds from the bond issue will also be used for acquisitions, investments and general corporate purposes. 

In accordance with the terms and conditions, the bonds are intended to be listed and admitted to trading on the corporate bond list at Nasdaq Stockholm shortly. As a result, the Company has prepared a prospectus which today has been approved by and registered with the Swedish Financial Supervisory Authority.

Vinges team consisted of Louise Brorsson Salomon, David Andersson, Sabina Börjesson, Josefine Larsson, André Isacson, Lionardo Ojeda and William Kåge

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025